trial
as of 2026-07-01Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia
NCTId NCT01052389
at a glance
Phase 4 · Completed
Enrollment 300 (actual)
Sponsored by Mario Negri Institute for Pharmacological Research
Primary completion 2012-06
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
300 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2007-07
Primary completion
2012-06
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Bristol-MyersCollaborator
Investigators
4
Angelo Barbato, M.D.Principal Investigator
Alberto Parabiaghi, M.D.Study Director
Barbara D'Avanzo, Phil.D.Study Chair
Mauro Tettamanti, Biol.D.Study Chair
Sites
1 total
Genoa, Italy
Facts & assertions
4 sourced
Enrollment
300
Phase
PHASE4
Primary Completion Date
2012-06
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication
investigator
person
person